Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAMBRIDGE NUTRITIONAL SCIENCES PLC Director's Dealing 2014

Mar 5, 2014

7544_dirs_2014-03-05_be0dfdcf-2a37-41ff-892c-b20d1e8df1ac.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6113B

Omega Diagnostics Group PLC

05 March 2014

Omega Diagnostics Group PLC

("Omega" or the "Company")

Director/PDMR Shareholding

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that the following Directors of the Company have today purchased ordinary shares of 4p each in the Company as follows:

Name No. of shares Price per share
Andrew Shepherd 18,000 29.935 pence
Jag Grewal 19,691 30.25 pence

Following this transaction, Mr Shepherd's total beneficial holding has increased to 2,677,206 ordinary shares representing 2.46% of the total voting rights of the Company and Mr Grewal's total beneficial holding has increased to 49,103 ordinary shares representing 0.05% of the total voting rights of the Company.

Contacts:

Omega Diagnostics Group PLC Tel: 01259 763 030
Andrew Shepherd, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Christopher Raggett (Corporate Finance)
Stephen Norcross/Mia Gardner (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBSGDXLXGBGSU